This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biomarin Pharmaceutical Inc (BMRN)

: Health Care

Company Cash Flow
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Cash Flow From Operating Activities
Net Income (Loss) -171.80M -133.97M -176.35M -114.35M
Operating Gains/Losses -372.52M -76.72M 1.15M 12.01M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -16.37M -26.65M -8.76M -4.23M
(Increase) Decrease in Inventories -50.99M -36.85M -33.91M 1.42M
(Increase) Decrease In Other Current Assets 25.80M -2.21M -12.07M -3.51M
(Decrease) Increase In Payables 90.30M 38.71M 20.42M 37.41M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Working Capital -2.41M -3.34M 11.23M 1.96M
Other Non-Cash Items 303.76M 129.01M 94.77M 47.05M
Net Cash From Continuing Operations -221.69M -73.54M -59.63M 17.61M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -221.69M -73.54M -59.63M 17.61M
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -227.65M -118.83M -65.12M -44.57M
Acquisitions -538.39M 0.00 -9.88M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 38.24M -493.82M -116.50M -5.00M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.18B 194.56M -298.78M -195.65M
Issuance of Debt 0.00 0.00 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 951.30M 197.37M 66.18M 316.90M
Repayment of Long-Term Debt 0.00 0.00 -13.57M -5.08M
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -23.39M -11.68M 694.06M 473.00K
Net Cash From Financing Activities 927.91M 185.69M 746.67M 312.29M
Effect of Exchange Rate Changes -5.07M 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents -478.45M 306.70M 388.25M 134.25M
BMRN News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

BMRN Biomarin Pharmaceutical Inc

Chart of BMRN

Analysts Ratings for BMRN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 11 10 9
Moderate Buy 2 2 2 1
Hold 2 2 3 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET BMRN ANALYST REPORT

BMRN Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs